SEC Form 4 · accession 0000899243-16-013772
PALVELLA THERAPEUTICS, INC. · PVLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chau Quang Khuong
Director · 10% Owner
Period of report
Feb 16, 2016
Accepted (ET)
Feb 18, 2016 · 7:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583648
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $1.59 | Feb 16, 2016 | A | 20,000 | A | — | Feb 16, 2026 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The Reporting Person is an employee of OrbiMed Advisors LLC ("Advisors") and is obligated to transfer any shares issued under equity grants made to him by the Issuer, or the economic benefits thereof, to Advisors for the ultimate benefit of OrbiMed Private Investments III, LP and OrbiMed Associates III, LP.
- F2The stock option will vest in four equal installments on each of March 31, June 30, September 30, and December 31, 2016.